Humana (HUM) Aandeel Koers
Humana Koers
In de afgelopen 19 jaar liet Humana de omzet jaarlijks met 9,9% groeien tot 129,66 Miljard USD. De winst per aandeel is de afgelopen 19 jaar met 6,7% per jaar gegroeid. Bij Humana is de nettowinstmarge met 0,9% ten opzichte van 3,5% enkele jaren geleden gedaald. Op de huidige koers komt het dividendrendement uit op ongeveer 0,84%. De uitkeringsratio ligt rond 36% van de winst. Het dividend is de afgelopen 14 jaar met 11,7% per jaar gegroeid. Het consensus-koersdoel voor Humana op 12 maanden bedraagt 412,50 USD, circa 2,7% onder de huidige koers. Van de 32 analisten geven 16 het aandeel een koopadvies — per saldo een Kopen-consensus.
Humana aandeelkoers
Deze data ophalen via de Eulerpool API
100.000 requests/maand gratis · geen creditcard
Humana bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over Humana
The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.
Humana Inc is primarily active in the healthcare industry. With a focus on offering a wide range of health insurance products and services, Humana serves individuals, employers, military service members, and their families. The company provides various medical and specialty health products, including Medicare Advantage plans, prescription drug plans, dental, vision, and wellness programs. With an extensive network of healthcare providers, Humana aims to improve the health and well-being of its members by delivering personalized and comprehensive healthcare solutions. As one of the leading healthcare companies, Humana Inc plays a crucial role in the provision of accessible and quality healthcare services.
The main competitors of Humana Inc in the market include UnitedHealth Group Incorporated, Anthem, Inc., and CVS Health Corporation.
Humana Inc is a leading healthcare company founded in 1961 and headquartered in Louisville, Kentucky. With a rich history spanning over five decades, Humana has emerged as a trusted name in the industry. Originally a nursing home business, Humana quickly expanded its operations to provide comprehensive health insurance services. Today, it offers a wide range of healthcare products and services, including Medicare and Medicaid plans, commercial health insurance, and specialty benefits. Through strategic acquisitions and partnerships, Humana has consistently grown its presence, providing innovative and accessible healthcare solutions to millions of customers across the United States. The company's commitment to customer-centric care and its extensive industry experience have solidified Humana Inc's position as a prominent player in the healthcare sector.
Humana Inc, a renowned healthcare company, has achieved several significant milestones throughout its history. One notable achievement was the company's inclusion in the Fortune 500 list, highlighting its position among the top-ranked businesses in the United States. Additionally, Humana Inc has consistently expanded its presence and diversified its offerings, successfully establishing itself as a leading provider of health insurance, wellness programs, and healthcare services. The company has also been recognized for its commitment to innovation, earning accolades for its progressive approach to healthcare delivery. Humana Inc's dedication to improving customer satisfaction and promoting healthy living has contributed to its widespread success in the industry.
Humana Inc is primarily present in the United States.
Humana Inc is committed to enhancing the well-being of people and making healthcare more accessible. The company's corporate philosophy revolves around delivering value-based care, focusing on the whole person, and improving the health outcomes of its members. Humana prioritizes innovation and technology to provide personalized and affordable healthcare solutions. With a focus on preventive care and wellness programs, Humana aims to empower individuals to live healthier lives. By fostering a culture of inclusion, collaboration, and integrity, Humana strives to be a trusted partner for its members, employees, and communities it serves.
Analisten hanteren momenteel een gemiddeld koersdoel van 416,78 USD voor het aandeel Humana (mediaan: 412,50 USD), oftewel -1,7 % ten opzichte van de laatste koers. De consensus is gebaseerd op 32 analistenratings.
32 analisten beoordelen het aandeel Humana momenteel: 16 adviseren kopen, 15 houden en 1 verkopen. Voor 2026 verwachten analisten dat Humana een omzet van 162,56 Miljard USD en winst per aandeel van 9,14 USD behaalt.
Omgezet tegen de huidige wisselkoers noteert het aandeel Humana op 378,14 EUR (423,86 USD).
Het aandeel Humana (HUM) is genoteerd aan 7 beurzen, waaronder: NYSE (HUM), London (0J6Z.L), SIX (Zürich) (HUM.SW), Frankfurt (HUM.F), München (HUM.MU), Düsseldorf (HUM.DU).
Humana Inc is a global healthcare company based in Louisville, Kentucky. It offers various products and services in healthcare, health insurance, and lifelong health solutions. They provide insurance for different areas such as medical, dental, vision, and travel. Additionally, they have specialized insurance plans for seniors and people with chronic illnesses. Humana also operates clinics and medical centers, offering a wide range of medical services including prevention, diagnosis, and treatment. They invest in research and development of medical technologies to improve healthcare. In terms of lifelong health solutions, Humana has programs like Humana GO365 that reward healthy behaviors. They also operate pharmacies and offer specialized pharmacy services. Humana's business model aims to provide tailored health solutions and insurance products to meet each customer's needs.
De verwachte omzet van Humana bedraagt 162,56 Miljard USD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.
De verwachte winst van Humana bedraagt 1,10 Miljard USD. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.
De koers-winstverhouding (P/E) van Humana bedraagt momenteel 46,39. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het Humana-aandeel in te schatten.
De koers-omzetverhouding (P/S) van Humana bedraagt momenteel 0,31. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het Humana-aandeel.
De Eulerpool Kwaliteitsscore voor Humana is 5/10.
De ISIN van Humana is US4448591028. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
De WKN van Humana is 856584. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.
Het tickersymbool van Humana is HUM. Onder dit beurstickersymbool wordt het Humana-aandeel op de beurs verhandeld.
Humana aandeel
Humana Ticker
Humana FIGI
Alle fundamentals en diepgaande analyse van Humana
Onze aandelenanalyse van het Humana-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van Humana. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: